Read + Share
Amedeo Smart
Independent Medical Education
Ewen T, Husain A, Stefanos N, Barrett P, et al. Validation of Epidermal AMBRA1 and Loricrin (AMBLor) as a prognostic biomarker for non-ulcerated AJCC stage I/II cutaneous melanoma. Br J Dermatol 2023 Nov 25:ljad459. doi: 10.1093.PMID: 38006317
Email
LinkedIn
Facebook
Twitter
Privacy Policy